Aozhi Dai

1.4k total citations
25 papers, 1.1k citations indexed

About

Aozhi Dai is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Aozhi Dai has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Genetics. Recurrent topics in Aozhi Dai's work include Estrogen and related hormone effects (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Aozhi Dai is often cited by papers focused on Estrogen and related hormone effects (7 papers), Atherosclerosis and Cardiovascular Diseases (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Aozhi Dai collaborates with scholars based in Australia, China and Germany. Aozhi Dai's co-authors include Shanhong Ling, Paul A. Komesaroff, Krishnankutty Sudhir, Zhi‐Xin Guo, Maro R. I. Williams, Ruizhi Luo, Kathy Myles, Zhi-Jiang Zhang, Alan Bensoussan and John W. Funder and has published in prestigious journals such as Circulation, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Aozhi Dai

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aozhi Dai Australia	17	326	324	154	149	112	25	1.1k
Shanhong Ling Australia	19	434 1.3×	346 1.1×	222 1.4×	161 1.1×	137 1.2×	29	1.3k
Jing Yu China	23	209 0.6×	782 2.4×	146 0.9×	68 0.5×	115 1.0×	66	1.6k
Kanchan Bhatia United States	23	130 0.4×	409 1.3×	64 0.4×	77 0.5×	79 0.7×	39	1.5k
Dan Liao China	21	140 0.4×	405 1.3×	85 0.6×	47 0.3×	69 0.6×	55	1.4k
In Kyeom Kim South Korea	20	128 0.4×	626 1.9×	95 0.6×	55 0.4×	70 0.6×	54	1.3k
Sunhapas Soodvilai Thailand	19	125 0.4×	474 1.5×	103 0.7×	41 0.3×	100 0.9×	68	1.2k
María Soledad Avendaño Spain	16	98 0.3×	321 1.0×	91 0.6×	71 0.5×	86 0.8×	25	1.0k
Vaddi Damodara Reddy India	21	113 0.3×	352 1.1×	151 1.0×	92 0.6×	49 0.4×	62	1.3k
Shujun Jiang China	22	108 0.3×	467 1.4×	71 0.5×	52 0.3×	138 1.2×	79	1.3k
A Marañón Spain	16	322 1.0×	423 1.3×	58 0.4×	33 0.2×	73 0.7×	28	1.2k

Countries citing papers authored by Aozhi Dai

Since Specialization

Citations

This map shows the geographic impact of Aozhi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aozhi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aozhi Dai more than expected).

Fields of papers citing papers by Aozhi Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aozhi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aozhi Dai. The network helps show where Aozhi Dai may publish in the future.

Co-authorship network of co-authors of Aozhi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Aozhi Dai. A scholar is included among the top collaborators of Aozhi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aozhi Dai. Aozhi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jandeleit‐Dahm, Karin, Aozhi Dai, Jaroslawna Meister, et al.. (2024). Endothelial NOX5 Obliterates the Reno-Protective Effect of Nox4 Deletion by Promoting Renal Fibrosis via Activation of EMT and ROS-Sensitive Pathways in Diabetes. Antioxidants. 13(4). 396–396. 5 indexed citations

Ho, Florence, Anna M.D. Watson, Mahmoud H. Elbatreek, et al.. (2022). Endothelial reactive oxygen-forming NADPH oxidase 5 is a possible player in diabetic aortic aneurysm but not atherosclerosis. Scientific Reports. 12(1). 11570–11570. 15 indexed citations

Jha, Jay C., Aozhi Dai, Jakob Appel Østergaard, et al.. (2022). Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways. Diabetes. 71(6). 1282–1298. 41 indexed citations

Ren, Shuting, Pengfei Sun, Tieqiao Wu, et al.. (2021). Ultrasound combined with microbubbles enhances the renoprotective effects of methylprednisolone in rats with adriamycin-induced nephropathy. European Journal of Pharmaceutical Sciences. 159. 105714–105714. 5 indexed citations

Jha, Jay C., Aozhi Dai, Chet E. Holterman, et al.. (2019). Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse. Diabetologia. 62(9). 1712–1726. 40 indexed citations

Watson, Anna M.D., Sally A. Penfold, Gavin Lambert, et al.. (2019). Diabetes and Hypertension Differentially Affect Renal Catecholamines and Renal Reactive Oxygen Species. Frontiers in Physiology. 10. 309–309. 14 indexed citations

Chai, Zhonglin, Tieqiao Wu, Aozhi Dai, et al.. (2018). Targeting the CDA1/CDA1BP1 Axis Retards Renal Fibrosis in Experimental Diabetic Nephropathy. Diabetes. 68(2). 395–408. 18 indexed citations

Jha, Jay C., Aozhi Dai, Mark E. Cooper, et al.. (2018). NADPH Oxidase Nox5 Aggravates Renal Injury in Akita Mouse Model of Diabetic Nephropathy. Diabetes. 67(Supplement_1). 1 indexed citations

Chai, Zhonglin, Aozhi Dai, Jiaze Li, et al.. (2013). Genetic Deletion of Cell Division Autoantigen 1 Retards Diabetes-Associated Renal Injury. Journal of the American Society of Nephrology. 24(11). 1782–1792. 24 indexed citations

10.

Wu, Tieqiao, Aozhi Dai, Phyllis Chew, et al.. (2010). Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy. Kidney International. 79(2). 199–209. 27 indexed citations

11.

Ling, Shanhong, Aozhi Dai, Zhi‐Xin Guo, & Paul A. Komesaroff. (2008). A Preparation of Herbal Medicine Salvia miltiorrhiza Reduces Expression of Intercellular Adhesion Molecule-1 and Development of Atherosclerosis in Apolipoprotein E-Deficient Mice. Journal of Cardiovascular Pharmacology. 51(1). 38–44. 24 indexed citations

12.

Ling, Shanhong, Ruizhi Luo, Aozhi Dai, et al.. (2008). A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts. Phytomedicine. 16(1). 56–64. 21 indexed citations

13.

Ling, Shanhong, Aozhi Dai, Zhi-Jiang Zhang, et al.. (2008). A Chinese Herbal Preparation Containing Radix Salviae Miltiorrhizae, Radix Notoginseng and Borneolum Syntheticum Reduces Circulating Adhesion Molecules. Evidence-based Complementary and Alternative Medicine. 2011(1). 790784–790784. 249 indexed citations

14.

Ling, Shanhong, et al.. (2007). Effects of four medicinal herbs on human vascular endothelial cells in culture. International Journal of Cardiology. 128(3). 350–358. 56 indexed citations

15.

Ling, Shanhong, Liemin Zhou, Aozhi Dai, et al.. (2006). Effects of 17β-estradiol on growth and apoptosis in human vascular endothelial cells: Influence of mechanical strain and tumor necrosis factor-α. Steroids. 71(9). 799–808. 35 indexed citations

16.

Ling, Shanhong, Aozhi Dai, Zhi‐Xin Guo, Xijun Yan, & Paul A. Komesaroff. (2005). EFFECTS OF A CHINESE HERBAL PREPARATION ON VASCULAR CELLS IN CULTURE: MECHANISMS OF CARDIOVASCULAR PROTECTION. Clinical and Experimental Pharmacology and Physiology. 32(7). 571–578. 49 indexed citations

17.

Ling, Shanhong, Aozhi Dai, Rodney J. Dilley, et al.. (2004). Endogenous Estrogen Deficiency Reduces Proliferation and Enhances Apoptosis-Related Death in Vascular Smooth Muscle Cells. Circulation. 109(4). 537–543. 52 indexed citations

18.

Williams, Maro R. I., Tye Dawood, Shanhong Ling, et al.. (2004). Dehydroepiandrosterone Increases Endothelial Cell Proliferationin Vitroand Improves Endothelial Functionin Vivoby Mechanisms Independent of Androgen and Estrogen Receptors. The Journal of Clinical Endocrinology & Metabolism. 89(9). 4708–4715. 113 indexed citations

19.

Ling, Shanhong, Aozhi Dai, Maro R. I. Williams, et al.. (2004). The Isoflavone Metabolite Cis-Tetrahydrodaidzein Inhibits ERK-1 Activation and Proliferation in Human Vascular Smooth Muscle Cells. Journal of Cardiovascular Pharmacology. 43(5). 622–628. 10 indexed citations

20.

Williams, Maro R. I., Shanhong Ling, Tye Dawood, et al.. (2002). Dehydroepiandrosterone Inhibits Human Vascular Smooth Muscle Cell Proliferation Independent of ARs and ERs. The Journal of Clinical Endocrinology & Metabolism. 87(1). 176–181. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact